
    
      Total study duration up to 74 weeks: screening up to 4 weeks, AID assessment phase of 12
      weeks, extension phase of 52 weeks and post-treatment follow-up of 6 weeks.

      For participants not entering the extension phase, total study duration up to 22 weeks
      (screening, AID assessment phase and follow-up).
    
  